Premium
Positron emission tomography and positron emission tomography‐CT evaluation for recurrent papillary thyroid carcinoma: Meta‐analysis and literature review
Author(s) -
Miller Mia E.,
Chen Qiaolin,
Elashoff David,
Abemayor Elliot,
St. John Maie
Publication year - 2011
Publication title -
head and neck
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 1.012
H-Index - 127
eISSN - 1097-0347
pISSN - 1043-3074
DOI - 10.1002/hed.21492
Subject(s) - positron emission tomography , thyroid carcinoma , medicine , thyroid cancer , nuclear medicine , carcinoma , radiology , meta analysis , thyroid , pet ct
Background Sensitivity and specificity data regarding positron emission tomography (PET) and PET/CT for surveillance of well‐differentiated thyroid cancer does not evaluate subtypes separately. Papillary and follicular thyroid carcinoma may have different characteristics on PET/CT imaging and so should be investigated individually. Methods This is a systematic meta‐analysis of studies using PET for surveillance in patients with papillary thyroid carcinoma. Results Using different statistical models, combined sensitivity of PET and PET/CT for papillary thyroid carcinoma was 77% by the fixed effect model and 82% by the random‐effects model, specificity was calculated as 85% and 84%, respectively. Meta‐regression was performed to evaluate whether I‐131 negativity affected PET positivity; no correlation between I‐131 negativity and PET sensitivity or specificity was found. Conclusion PET and PET/CT are useful modalities in surveillance of papillary thyroid carcinoma. To our knowledge, this is the first study to examine papillary thyroid carcinoma independently of other subtypes of well‐differentiated thyroid carcinoma. © 2010 Wiley Periodicals, Inc. Head Neck, 2011
Accelerating Research
Robert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom
Address
John Eccles HouseRobert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom